NOX1/4

Class

NADPH oxidase inhibitor

NOX1 and NOX4 are members of the NADPH oxidase family, membrane-bound enzymes whose sole function is to generate reactive oxygen species (ROS) such as superoxide and hydrogen peroxide by transferring electrons from NADPH to molecular oxygen. Unlike the ROS produced incidentally by mitochondria, NOX-derived ROS act as deliberate signaling molecules that regulate cell growth, inflammation, and tissue remodeling. When NOX1 or NOX4 activity becomes chronically elevated, the resulting oxidative signaling can drive fibroblasts to become collagen-producing myofibroblasts, promote vascular smooth muscle changes, and sustain inflammatory signaling in epithelial tissues. This places the NOX1/4 pair at the center of fibrotic and vascular disease biology, including conditions affecting the kidney, lung, liver, and blood vessels, where excessive scarring or oxidative vascular injury are central to disease progression. Inhibiting both isoforms together, rather than either alone, is intended to address overlapping contributions: NOX4 as a steady driver of fibrotic signaling in stressed or injured tissue, and NOX1 as a contributor to vascular and mucosal oxidative stress. A combined inhibitor aims to dampen this shared oxidative signaling axis across several organ systems without broadly suppressing all NADPH oxidase activity in the body, since other family members serve distinct and largely non-overlapping physiological roles.